West Africa is a region with about 250 million people, comprising of
Nigeria, Ghana, Cote D Voire, Togo, Niger among others. The sub-region is
almost a third of the whole of Africa.
The West Africa Pharmaceutical Industry consists of Manufacturers and
Importers of pharmaceutical. Imports of pharmaceutical finished products
accounts for over 60% of the pharmaceutical industry.
There is a strong presence of
pharmaceutical manufacturers in
the sub-region, there are currently over 200 active manufacturers of
pharmaceutical in West Africa.
According to IMS forecast, Nigeria’s
Pharma business is worth about
$2.5 billion serving 150 million Nigerians. The pharmaceutical market in
West Africa has been growing at between 5% - 7% annually. The market is
expected to rise steadily in the next few years.
1. Global Pharma Market Scenario
2. Challenges and Opportunities of West African Pharma Industry
3. Strategic Alliances and M & A in the Pharma Industry
4. Distribution / Logistics in the pharmaceutical industry
5. Active raw ingredients for pharmaceutical production
6. Pharmaceuticals for special diseases
ABOUT PHARMA WEST AFRICA 2008
Pharma West Africa 2008 is an
International Exhibition and Conference
focusing on pharmaceutical equipments, raw materials, active ingredients,
processing machinery, packaging machinery, equipments and related services
for the Pharma sector to be hosted in Nigeria at the Yar’Adua International
Conference Centre, Abuja. Pharma West Africa 2008 is an International trade
exhibition targeting international manufacturers and traders interested in
the African market. It is a trade event brings together the industry’s most
respected leaders, associations and government agencies to discuss how to
effectively manage cost efficiency.
It is a trade Expo that will put you on the leading edge and provide you
with new exciting opportunities you will not find anywhere else at one place
at one time.
Pharma West Africa & 1st Pharmaceutical Manufacturer’s Day
Dates : June 4th – 6th, 2008
Time : 9am – 5pm
Venue : Shehu Musa Yar’Adua Conference Centre, Abuja.
Address : One Memorial Drive, FCT, Abuja
Organizer : Global Resources & Projects (Nig) Ltd
Supported by : Pharmacy Society of Nigeria (PSN)
Federal Ministry of Health, Nigeria
Pharmaceutical Manufacturers Group of MAN
Association of Pharmaceutical Importers of Nigeria
National Agency for Food and Drug Administration & Control
French Embassy Middle East pharma market in near future
The pharmaceutical and biotechnology
markets of the Middle East countries that are currently valued at more than
$12 billion are forecasted to boom in the near future, reported Pharma
Suppliers to this Sector
*Bürkert Fluid Control Systems
From the control room to the downstream processing ...
*STARLIMS solutions for the pharmaceutical and life ...
*Parenteral Drug Association
The Parenteral Drug Association (PDA) is the leadi ...
Suppliers Free White Papers
*QCM-D Study of Molecular Conformational Effects on Protein - DNA
dbbc82e9-09dd-4870-b123-77fa280e034fQCM-D Study of Molecular Conformational
Effects on Protein - DNA Interactions
Q-Sense Quartz Crystal Microbalance with Dissipati ...
According to PharmaTimes, the introduction of mass health insurance,
liberalization initiatives and the Middle East governments's desire to
become self-sufficient in pharmaceuticals production may herald a
prospective future for the global drug makers. Increased access to generics
and innovative new medicines due to spread of health insurance and rise in
chronic diseases are also believed to create wide opportunities of growth in
the middle east
The Middle East pharmaceutical market is expected to grow around 10%-15%
annually compared to less than 5% a year growth predicted in the mature
markets of the US and Europe.
Initiatives like offering free zones to overseas firms, including 100%
ownership and tax benefits, to set up within developments such as Saudi
Arabia's $534 million King Fahd Medical City in Riyadh and the Dubai
Biotechnology and Research Park, are expected to fuel rapid growth in the
region's overall market for biotechnology